2-178675038-C-T

Variant summary

Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PVS1_ModeratePP5

The NM_001267550.2(TTN):​c.34612+1G>A variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.0000158 in 1,523,594 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000016 ( 0 hom. )

Consequence

TTN
NM_001267550.2 splice_donor, intron

Scores

5
1
1
Splicing: ADA: 1.000
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:3U:1

Conservation

PhyloP100: 5.50

Publications

0 publications found
Variant links:
Genes affected
TTN (HGNC:12403): (titin) This gene encodes a large abundant protein of striated muscle. The product of this gene is divided into two regions, a N-terminal I-band and a C-terminal A-band. The I-band, which is the elastic part of the molecule, contains two regions of tandem immunoglobulin domains on either side of a PEVK region that is rich in proline, glutamate, valine and lysine. The A-band, which is thought to act as a protein-ruler, contains a mixture of immunoglobulin and fibronectin repeats, and possesses kinase activity. An N-terminal Z-disc region and a C-terminal M-line region bind to the Z-line and M-line of the sarcomere, respectively, so that a single titin molecule spans half the length of a sarcomere. Titin also contains binding sites for muscle associated proteins so it serves as an adhesion template for the assembly of contractile machinery in muscle cells. It has also been identified as a structural protein for chromosomes. Alternative splicing of this gene results in multiple transcript variants. Considerable variability exists in the I-band, the M-line and the Z-disc regions of titin. Variability in the I-band region contributes to the differences in elasticity of different titin isoforms and, therefore, to the differences in elasticity of different muscle types. Mutations in this gene are associated with familial hypertrophic cardiomyopathy 9, and autoantibodies to titin are produced in patients with the autoimmune disease scleroderma. [provided by RefSeq, Feb 2012]
TTN-AS1 (HGNC:44124): (TTN antisense RNA 1) This gene encodes a non-coding RNA transcribed from the opposite strand to the titin gene. [provided by RefSeq, Aug 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 3 ACMG points.

PVS1
Splicing +-2 bp (donor or acceptor) variant, product NOT destroyed by NMD, known LOF gene, truncates exone, which is 6.945988E-4 fraction of the gene. No cryptic splice site detected. Exon removal is inframe change.
PP5
Variant 2-178675038-C-T is Pathogenic according to our data. Variant chr2-178675038-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 404922. Variant chr2-178675038-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 404922. Variant chr2-178675038-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 404922. Variant chr2-178675038-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 404922. Variant chr2-178675038-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 404922. Variant chr2-178675038-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 404922. Variant chr2-178675038-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 404922. Variant chr2-178675038-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 404922. Variant chr2-178675038-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 404922. Variant chr2-178675038-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 404922. Variant chr2-178675038-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 404922. Variant chr2-178675038-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 404922. Variant chr2-178675038-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 404922. Variant chr2-178675038-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 404922. Variant chr2-178675038-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 404922. Variant chr2-178675038-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 404922. Variant chr2-178675038-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 404922. Variant chr2-178675038-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 404922. Variant chr2-178675038-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 404922. Variant chr2-178675038-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 404922. Variant chr2-178675038-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 404922.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TTNNM_001267550.2 linkc.34612+1G>A splice_donor_variant, intron_variant Intron 150 of 362 ENST00000589042.5 NP_001254479.2 A0A0A0MTS7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TTNENST00000589042.5 linkc.34612+1G>A splice_donor_variant, intron_variant Intron 150 of 362 5 NM_001267550.2 ENSP00000467141.1 A0A0A0MTS7

Frequencies

GnomAD3 genomes
AF:
0.0000132
AC:
2
AN:
151844
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000658
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000161
AC:
3
AN:
185860
AF XY:
0.0000195
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000329
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000160
AC:
22
AN:
1371750
Hom.:
0
Cov.:
26
AF XY:
0.0000162
AC XY:
11
AN XY:
680558
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
28010
American (AMR)
AF:
0.00
AC:
0
AN:
29788
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24080
East Asian (EAS)
AF:
0.00
AC:
0
AN:
33564
South Asian (SAS)
AF:
0.0000143
AC:
1
AN:
69768
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52352
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5578
European-Non Finnish (NFE)
AF:
0.0000196
AC:
21
AN:
1071830
Other (OTH)
AF:
0.00
AC:
0
AN:
56780
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000132
AC:
2
AN:
151844
Hom.:
0
Cov.:
32
AF XY:
0.0000270
AC XY:
2
AN XY:
74186
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41370
American (AMR)
AF:
0.0000658
AC:
1
AN:
15192
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5196
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
67870
Other (OTH)
AF:
0.00
AC:
0
AN:
2086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.550
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000417
Hom.:
0
Bravo
AF:
0.00000756
ExAC
AF:
0.0000166
AC:
2

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:3Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Autosomal recessive limb-girdle muscular dystrophy type 2J Pathogenic:1
Jan 16, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: TTN NM_133378: c.30709+1G>A (also known as NM_001267550: c.34612+1G>A) is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Several computational tools predict a significant impact on normal splicing: Three predict the variant abolishes a 5' splicing donor site. However, these predictions have yet to be confirmed by functional studies. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing and loss of TTN function. Loss of function variants in all TTN bands are strongly associated with a spectrum of autosomal recessive titinopathies when exon expression (proportion spliced in, PSI, 1=complete expression) in skeletal muscle is >0.1 (PMID: 36977548, 39198997, 29598826, 32778822, 29691892, 33449170, 36977548, internal data). In contrast, loss of function variants in all TTN bands are only strongly associated with autosomal dominant TTN-related cardiomyopathies if located in exons constitutively expressed (PSI >0.9) in cardiac muscle, excluding extreme C-terminal exons 359-363 (PMID: 25589632, 31216868, 32964742, 34662387, 27869827, Shetty et al., Nat Cardiovasc Res 2024, cardiodb.org, internal data). This variant has a maximum skeletal muscle PSI of 0.582 and a maximum cardiac muscle PSI of 0.2. The variant allele was found at a frequency of 1.6e-05 in 185860 control chromosomes. To our knowledge, no occurrence of c.30709+1G>A in individuals affected with TTN-related conditions and no experimental evidence demonstrating its impact on protein function have been reported. However, it has been reported in at-least two control individuals of European ancestery in the UK Biobank (e.g., Choi_2020). These reports do not provide unequivocal conclusions about association of the variant with TTN-related conditions. The following publication has been ascertained in the context of this evaluation (PMID: 31691645). ClinVar contains an entry for this variant (Variation ID: 404922). Based on the evidence outline above, the variant has been classified as likely pathogenic for autosomal recessive TTN-related conditions. -

Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G Pathogenic:1
Jan 26, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change affects a donor splice site in intron 150 of the TTN gene. It is expected to disrupt RNA splicing and likely results in a truncated or disrupted TTN protein. This variant is present in population databases (rs577363824, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with TTN-related conditions. ClinVar contains an entry for this variant (Variation ID: 404922). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant is located in the I band of TTN (PMID: 25589632). Truncating variants in this region have been reported in individuals affected with autosomal recessive centronuclear myopathy (PMID: 23975875, internal data). Truncating variants in this region have also been identified in individuals affected with autosomal dominant dilated cardiomyopathy and/or cardio-related conditions (PMID: 27869827, 32964742, internal data). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -

not provided Pathogenic:1
Jul 21, 2016
Genetic Services Laboratory, University of Chicago
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Uncertain:1
Apr 08, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.34
D
BayesDel_noAF
Pathogenic
0.35
CADD
Pathogenic
29
DANN
Uncertain
0.99
Eigen
Pathogenic
1.0
Eigen_PC
Pathogenic
0.85
FATHMM_MKL
Pathogenic
0.97
D
PhyloP100
5.5
GERP RS
5.6
Mutation Taster
=0/100
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.90
SpliceAI score (max)
0.99
Details are displayed if max score is > 0.2
DS_DL_spliceai
0.99
Position offset: 1

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs577363824; hg19: chr2-179539765; API